Concepedia

Publication | Open Access

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

DOIFull Paper Access

252

Citations

49

References

2023

Year

Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg, Anas Gazzah, Ulrik Lassen, Alexander Stein, Patrick Y. Wen, Sascha Dietrich, Maja J.A. de Jonge, Jean‐Yves Blay,
Nature Medicine

References

YearCitations

Page 1